TWO SIGMA INVESTMENTS, LP - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$59,890,245
+72.2%
2,206,715
+95.0%
0.16%
+85.1%
Q2 2023$34,788,335
+454.0%
1,131,696
+549.3%
0.09%
+383.3%
Q1 2023$6,279,453
-63.9%
174,284
-60.4%
0.02%
-67.3%
Q4 2022$17,393,108
-45.3%
440,109
-44.4%
0.06%
-49.1%
Q3 2022$31,796,000
+60.6%
791,340
+68.0%
0.11%
+66.2%
Q2 2022$19,799,000
+171.7%
470,947
+151.8%
0.06%
+195.5%
Q1 2022$7,287,000
+13.7%
187,027
+16.3%
0.02%
+57.1%
Q4 2021$6,407,000160,7750.01%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders